Google Alert - lose weight

	lose weight As-it-happens update ⋅ June 22, 2025
	NEWS
	Cagrilintide–Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes The New England Journal of Medicine Cagrilintide and semaglutide have each been shown to induce weight loss as monotherapies. Data are needed on the coadministration of cagrilintide ... Flag as irrelevant
	CagriSema confers 'robust' weight loss in patients with obesity, with or without diabetes Healio CHICAGO — The combination of once-weekly cagrilintide 2.4 mg and semaglutide 2.4 mg conferred greater weight loss at 68 weeks compared with ... Flag as irrelevant
See more results | Edit this alert

You have received this email because you have subscribed to Google Alerts. Unsubscribe | View all your alerts

Receive this alert as RSS feed

Send Feedback